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T 
he seminal discovery by Mosmann and Coffman (1) that 
long-term CD4 + T cell clones could be segregated into 
subsets  that produce distinct types of cytokines opened the 
way for extensive study of how these subsets  are generated 
and what role they play in immune regulation as it relates 
to disease. Following this observation it quickly became evi- 
dent in a murine model of Leishmaniasis  that CD4 + T cells 
from mice that produced a Thl response characterized by 
production of IFN-qr were cured, while mice expressing a 
Th2 response characterized by II.,4 production were suscep- 
tible to disease (2). These studies established that functional 
T helper subsets existed in vivo. After these observations several 
groups became interested in the mechanism by which naive 
CD4 +  T  ceils  differentiated into  Thl  or Th2  type cells. 
From these studies it became clear that lymphokines them- 
selves exert a powerful regulatory influence on this process 
(3,  4).  Moreover, I1:4 was shown to be required for Th2 
differentiation whereas I1:12 strikingly enhances the process 
of Thl development. These in vitro studies formed the basis 
of similar types of experiments with CD8 + T cells. The re- 
cent reports documenting the ability of CD8 T cells to de- 
velop activities normally associated  with CD4 + Th2 lym- 
phocytes encourage us to suggest the mechanism whereby 
CD8 + T  cells are involved in immune regulation. 
Development of CD8 + Th2 Cells In  Vitro 
In an early study it was demonstrated that naive CD8 + 
T  ceils cultured in vitro on anti-CD3-coated dishes in the 
presence of I1:4,  developed into CD8 T cells that produced 
I1:4 upon restimulation (5).  These findings were extended 
by Erard et al. (6) using mitogens or allostimulation in the 
presence of I1:4  to demonstrate that the CD8 T  cells not 
only switched to I1:4,  I1:5,  and I1:10  production but lost 
the potential for IFN-3"/I1:2 production and cytotoxic ac- 
tivity. Also the CD8 cells were found to be able to help B 
cells to antibody production through the expression of the 
CD40L. 
The article in a recent issue of The Journal of Experimental 
Medicine by Croft et al. (7) extends this phenomenon to more 
physiological antigens by studying the outcome of priming 
for CD8 §  T  cells using cells from mice transgenic for an 
TClk-od[3 that recognizes H-Y on Db. These workers demon- 
strated that by activating CD8 + T  cells in the presence of 
I1:2 or I1:12 for 4 d, they could generate CD8 + T cells that 
were able to produce I1:2 and IFN-y upon reactivation (7). 
By contrast the presence of I1:4 during effector cell genera- 
tion promoted the development of CD8 cells which produced 
II:4 and I1:5  and stopped producing IFN-3'. 
The potential consequences of a host CD8 T cell response 
being switched from delayed type hypersensitivity type effector 
functions to the so called Th2 pattern is discussed below. 
The Relationship of "Th2-Like" CD8  T  Cells to Disease 
The I1:4-induced induction of CD8 + Th2-1ike T  cells 
could have great relevance to immune responses against in- 
fectious agents. Specifically in situations where the cytotoxic 
activity and IFN-3' production by CD8 T  cells are protec- 
tive, the switch to I1:4, lb5 production would probably allow 
a pathogen to escape elimination. One such example, may 
be the in vivo studies performed by Actor et al. (8) who used 
a helminth infection to generate a Th2-type response and then 
challenged the mice with a recombinant vaccinia virus. They 
found that the anti-viral cytotoxic activity of the CD8 + T 
cells was suppressed by the helminth-induced Th2 immune 
response, and that this was associated with a delayed virus 
clearance from the host  (8).  Another example of such  a 
phenomenon could be the I1:4 and 11:5 producing CD8 T 
cells seen in the lesions of lepromatous leprosy patients (9). 
In a separate study we investigated whether virus specific 
CD8 cells could switch to I1:5 production and contribute 
to the lung inflammation characteristic of asthma (9a). An- 
tiviral CD8 responses were studied in transgenic mice ex- 
pressing a lymphocytic choriomeningitis virus peptide specific 
TCR-ot//~ in CD8 T cells. If these transgenic mice mounted 
a Th2-type immune response to an unrelated antigen before 
receiving the virus peptide challenge, a significant airway eo- 
sinophilia was induced. In vitro analysis  of the CD8 cells 
from the immunized mice revealed that they had switched 
to the production of II.-5. Taken together these results indi- 
cate that virus specific CD8 cells can switch effector func- 
tions in vivo and, interestingly, could explain the observed 
link between virus infection and acute exacerbation of asthma. 
The Good Side of Th2 like  CD8  T  Cells 
Using rat and murine models of experimental autoimmune 
encephalomyelitis (EAE) Weiner et al. (10) support the view 
that CD8 + T cells might indeed have an important role in 
protecting animals from EAE. They clearly show that TGF-/3 
and possibly I1:4  production by CD8 + T  cells,  after oral 
feeding with antigen, prevents mice from developing EAE. 
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may provide a "suppressor" or anti-inflammatory  function 
that  is beneficial to  the host. 
Do  Th2-1ike  CD8  T  Cells Have a Role in AIDS? 
Recent  studies have  suggested that  HIV-l-specific cyto- 
toxic CD8 + T  cells  have a protective (although  transient) 
role against  the onset of AIDS (11). During the protective 
phase there is a high frequency of HIV-l-specific CD8 + T 
cells that exhibit good cytotoxic activity against HIV-l-in- 
fected cell  targets.  In  patients  whose HIV-1  infection  has 
progressed to AIDS there is a significant  reduction  in the 
frequency of HIV-l-specific cytotoxic CD8 cells (12). In the 
same patients  the frequency of Epstein-Barr  virus  (EBV)- 
specific cytotoxic cells is not diminished.  This brings in to 
question the role that a Th2 response has in HIV infection 
and whether  there is  an  influence  of Ib4  on  CD8  T  cell 
function. 
The immunoregulatory influence  of IL-4 on CD8 + T cells 
in HIV infected individuals was recently addressed in the Au- 
gust edition of this journal by Maggi et al. (13). They gener- 
ated CD8 § T cell clones by limiting dilution analysis in re- 
sponse to mitogen and IL-2 from two patients with low CD4 
T cell counts and a Job's like syndrome (eczematous derma- 
titis, recurrent skin and sinopulmonary infections,  hyper IgE). 
They were able to generate many clones that expressed a Th2 
phenotype in response to anti-CD3 and PMA. Moreover,  they 
found that  the cytolytic activity of clones from the patient 
with a Job's like syndrome was significantly reduced com- 
pared to CD8 + Thl clones from HIV seronegative individ- 
uals. This striking observation demonstrates that CD8 cells 
in a situation where high amounts of IL-4 might be present 
(i.e., Job's syndrome) show diminished functional cytolytic 
activity.  One  caveat  to  these  studies  is  that  CD8 +  Th2 
clones from HIV seronegative individuals with or without 
Job's syndrome or seropositive individuals not afflicted with 
the Job's type illness were not examined for evidence of re- 
duced cytolytic activity.  In a similar  study in  this issue of 
The  Journal of  Expetimental Medicine, Paganeni et al. (14) studied 
a small number of HIV infected patients with CD4 counts 
<200,  and  a  syndrome  characterized  by high  IgE  levels, 
chronic dermatitis, repeated Staphylococcal abscesses and Can- 
dida infection. They were able to demonstrate that a majority 
of CD8 + T  cell lines  and clones produced Ib4 in response 
to anti-CD3. Moreover, they showed that the IL-4 produced 
by the  CD8 +  T  cells  was able to  induce  IgE  production 
from normal B cells in the presence of anti-CD40 costimula- 
tion.  These  authors  raise  the  question  of whether  these 
CD8 + Th2-type cells,  which  they isolate very late in dis- 
ease, appear as a consequence from an earlier Th2-dominated 
response. In this regard, it is clear from the studies outlined 
earlier that Ib4 is essential for CD8 cells to develop into Ib4 
producers, then the question remains as to what is its source? 
Clerici et al.  (15,  16) have done extensive work on charac- 
terizing the proliferative and cytokine response using peripheral 
blood mononuclear cells from HIV infected individuals  stimu- 
lated with various antigens.  They identified a group of pa- 
tients whose cells are unable to proliferate or generate IL-2 
in response to recall antigen but maintain these responses to 
alloantigens  and mitogens.  Moreover, in response to PHA 
these patients were capable of producing IL-4. They further 
argued that the Th2 phenotype correlates with a poor out- 
come. Based on this data one could speculate that  in these 
specific patients there exists the development of a vicious circle 
during HIV-1 infection which depletes and exhausts the specific 
cytotoxic CD8 cells by their Ib4-driven conversion into CD8 
TH2-1ike cells. Clearly, pathogens,  opportunistic infections 
and genetic factors would greatly influence the onset of such 
a vicious circle by their activation of Ib4-producing CD4 + 
T cells. Lastly,  the presence of IL-4 might also influence the 
types of T cells that develop.  This is supported by the work 
previously noted by Erard et al.  (6) showing conversion of 
CD8 + T  cells into CD3 +  CD4-CD8-  when cells are acti- 
vated in the presence of IL-4, and in the paper by Maggi et 
al.  (13)  which  showed  that  several  CD3+CD4-CD8 - 
clones derived from HIV-infected patients at end stage dis- 
ease produced Th2 cytokines. Consistent with this specula- 
tion, previous studies of large groups of HIV-l-infected in- 
dividuals have reported a significant increase  in the absolute 
number  of CD3 +  CD4- CD8-  peripheral  blood  lympho- 
cytes in the late stages of AIDS (17). 
One final caveat  to all of these studies is that  the ability 
to detect IL-4 protein in human  disease,  even from CD4 + 
T cells (the primary IL-4-producing cell) is usually in response 
to polyclonal stimulants  such as anti-CD3,  PHA, or PMA 
and  rarely  if ever  detected by  specific  antigen.  Moreover 
CD8 + Th2 clones that are generated in most of the studies 
cited here are rarely antigen-specific and again derived in the 
presence of mitogen.  Whether antigen-specific CD8 + Th2 
calls  or  clones  can be  derived  directly  in  vivo remains  a 
challenging  task. 
Conclusion 
The demonstration that IL-4 can induce mature CD8 + T 
cells  to develop Th2-type effector functions and lose cyto- 
toxic activity could have a major impact upon the way in 
which the role of CD8 T cells in heahh and disease is inves- 
tigated or therapeutically manipulated. It is too early to know 
whether these noncytotoxic, Th2-1ike CD8 ceUs are relevant 
as effector cells in antiviral immune responses. However, there 
is mounting evidence for their role in suppression of CD8 + 
T  cell-mediated cytotoxicity and IFN-7 production. Alter- 
natively, CD8 + Th2-type cells might  have a desirable role 
as "suppressor" or anti-inflammatory cells through its produc- 
tion  of "helper"  cytokines.  We would emphasize that  the 
classical  nomenclature  of helper  and suppressor cells  is no 
longer useful in  a general  sense. 
It is now fashionable to consider that many of the phe- 
nomena of the '70s and early '80s which were regarded as 
mediated by a unique population of suppressor T cells were, 
in fact, secondary to the differential production of cytokines 
by either  subsets of CD4  or CD8  T  cells.  Although  the 
identification of a unique subpopulation of CD8 cdls with 
a Th2 line phenotype raises  the possibility that  these cells 
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of suppressor cells, it is worth noting that the majority of 
the assays for suppressor cell activity involved suppression of 
antibody production as well as delayed type hypersensitivity. 
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